David Thompson’s doctors say a clinical trial will increase his chances of survival. 

Most women with the most common form of early-stage breast cancer can safely skip chemotherapy without hurting their chances of beating the disease, doctors are reporting from a landmark study that used genetic testing to gauge each patient's risk. 

Wireless industry's 5G service  is supposed to be up to 100 times faster than current data speeds, but it requires cellphone tower equipment to be closer to users than before. Some homeowners are concerned.

U.S. regulators have approved the first drug aimed at women with advanced breast cancer caused by an inherited flawed gene. 

An experimental gene therapy that turns a patient’s own blood cells into cancer killers worked in a major study, with more than one-third of very sick lymphoma patients showing no sign of disease six months after a single treatment, its maker said Tuesday.      

A Missouri jury has awarded $72 million to the family of an Alabama woman who died from ovarian cancer, which she said was caused by using Johnson & Johnson's well-known products containing talcum.